LYNKEUS BIOTECH
DEAD

Serial Number

76412499

Owner

LYNKEUS BioTech GmbH

Attorney

James D. DeCamp

Filing Date

May 24, 2002

Add to watchlist:

No watchlists yet
View on USPTO

LYNKEUS BIOTECH Trademark

Serial Number: 76412499 • Registration: 2986751

LYNKEUS BIOTECH is a trademark filed by LYNKEUS BioTech GmbH on May 24, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

LYNKEUS BioTech GmbH

Friedrich-Bergius-Ring 15
97076 Wurzburg , DE

Entity Type: 03

Trademark Details

Filing Date

May 24, 2002

Registration Date

August 23, 2005

Published for Opposition

May 31, 2005

Cancellation Date

September 21, 2012

Goods & Services

Educational services, namely, conducting seminars, lectures, academies, colloquiums, conferences, congresses, symposiums, workshops, practical training, in the field of molecular biology, genetic engineering, and molecular diagnostics

Pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases; veterinary pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases in domestic pets, live-stock, poultry, amphibians, teleosts and insects; preparations for healthcare, namely, dietetic products for medical purposes in the nature of dietary supplements, diet pills, dietary drink mix for use as a meal replacement, dietary food supplements, food for medically restricted diets, and meal replacement bars

Chemicals, namely, biochemical and molecular biological products for use in manufacture of pharmaceutical and veterinary pharmaceutical preparations for the diagnosis and therapy of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases; chemicals, namely, biochemical products and molecular biological products in the nature of nucleic acid probes and antibodies for the detection of degenerative diseases of the central nervous system, the eye, vasculature, and for the detection of autoimmune diseases for scientific use

Scientific research; technical research in the field of chemistry, biology and diagnosis of neuronal, especially opthalmological indications like retinal degradations and of diseases related to defects in vasculature or diseases related to vasculature and of autoimmune diseases; scientific research in the field of gene therapy; laboratory research in the field of molecular biology, animal models and cell culture systems; chemist services, biochemist services; technical consultation and research in the fields of biology; mission oriented research and diagnostics, namely, diagnostic services in the field of diagnostic services in the field of diseases of the eye, diseases related to defects in vasculature, and autoimmune diseases and genetic, biochemical, and medical research; chemical and biochemical laboratories; genealogy research in the nature of generating of gene therapy-protocols; computer software development for data processing; consultation in the fields of molecular biology, genetic engineering, molecular diagnostics, gene therapy, and molecular medicine; research in the field of gene therapy and molecular medicine

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 21, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2005 R.PR
PUBLISHED FOR OPPOSITION
May 31, 2005 PUBO
NOTICE OF PUBLICATION
May 11, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 9, 2004 PREV
ASSIGNED TO LIE
Aug 26, 2004 ALIE
PAPER RECEIVED
Jun 29, 2004 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2004 CNSA
CASE FILE IN TICRS
Mar 4, 2004 CFIT
ASSIGNED TO EXAMINER
Mar 3, 2004 DOCK
Sec. 1(B) CLAIM DELETED
Dec 8, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2003 CRFA
PAPER RECEIVED
Dec 8, 2003 MAIL
FINAL REFUSAL E-MAILED
Jun 5, 2003 GNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2003 CRFA
PAPER RECEIVED
Mar 25, 2003 MAIL
ASSIGNED TO EXAMINER
Oct 9, 2002 DOCK
NON-FINAL ACTION MAILED
Sep 23, 2002 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2002 DOCK